Results 121 to 130 of about 2,182,830 (147)

An Observational Retrospective Cohort Trial on 4,828 IVF Cycles Evaluating Different Low Prognosis Patients Following the POSEIDON Criteria. [PDF]

Front Endocrinol (Lausanne), 2019
Levi-Setti PE, Zerbetto I, Baggiani A, Zannoni E, Sacchi L, Smeraldi A, Morenghi E, De Cesare R, Drovanti A, Santi D.   +9 more
europepmc   +1 more source

Cumulative Live Birth Rates of Good and Low Prognosis Patients According to POSEIDON Criteria: A Single Center Analysis of 18,455 Treatment Cycles. [PDF]

Front Endocrinol (Lausanne), 2019
Shi W, Zhou H, Tian L, Zhao Z, Zhang W, Shi J.   +5 more
europepmc   +1 more source

Claiming bounties on small scale Poseidon and Poseidon2 instances using resultant-based algebraic attacks

In november 2024, the Ethereum foundation (EF) issued a bounty program with challenges on Poseidon and Poseidon2. The goal of these challenges is to find CICO solutions on different round-reduced instances of Poseidon and Poseidon2, defined on different ...
Maël Hostettler, Antoine Bak, Guilhem Jazeron, Augustin Bariant, Aurélien Boeuf   +4 more
core  

Management Strategies for POSEIDON's Group 1

Frontiers in Endocrinology, 2019
Nikolaos P. Polyzos, Nikolaos P. Polyzos, Nikolaos P. Polyzos, Panagiotis Drakopoulos, Panagiotis Drakopoulos   +4 more
doaj   +1 more source

Utilizing Machine Learning to Identify Multimodal Signatures for Patients Who Would Benefit from the Addition of Tremelimumab to Durvalumab and Chemotherapy (TRIDENT). [PDF]

Clin Cancer Res
Skoulidis F, Jabbour SK, Garon EB, Iyengar P, Scagliotti G, Ferrer L, Etchepare G, Gallinato O, Faure J, Bernard P, Colin T, Menu P, Lin Y, Cai L, Chaudhry AA, Remorino A, Stewart R, Luciani-Silverman L, Miller K, Dellamonica D, Faria J, Zhang Y.   +21 more
europepmc   +1 more source

The prognostic value of the Oocyte Maturation Index (OMI) on pregnancy outcomes in POSEIDON group 3 and 4 patients: a retrospective cohort study. [PDF]

J Ovarian Res
Bayram Y, Yildiz H, Ulger G, Durukan H, Tok D, Yazici FG.   +5 more
europepmc   +1 more source

Efficacy and safety of durvalumab with or without tremelimumab in the treatment of metastatic non-small cell lung cancer: a meta-analysis of randomized controlled trials. [PDF]

Proc (Bayl Univ Med Cent)
Matos UMA, Divina da Silva Santiago M, Guimaraes Barbosa Coelho H, Kaner F, Robinson N.   +4 more
europepmc   +1 more source

Ten years of POSEIDON classification: a SOAR analysis. [PDF]

Reprod Biol Endocrinol
Carton I, Humaidan P, Midassi H, Alviggi C, Blockeel C.   +4 more
europepmc   +1 more source

An injection-lite approach to ovarian stimulation in poor responder patients using corifollitropin alfa and nasal GnRH agonist. [PDF]

J Assist Reprod Genet
Arulpragasam K, Lieberman D, O'Neil M, Sweeten P, Dalati S, Shin JE, Tan J, Choi S, Briggs N, Barcelos I, Ledger W.   +10 more
europepmc   +1 more source

Clinical outcomes of the short agonist stop protocol versus the long GnRH agonist protocol in poor ovarian responders undergoing IVF/ICSI: a retrospective analysis. [PDF]

BMC Pregnancy Childbirth
Zhang XL, Chen YH, Wang J, Zhang ZP, Wu XQ, Wang XP, Zhang XP, Bi XY.   +7 more
europepmc   +1 more source